Therapeutic potential of morin against liver fibrosis in rats: Modulation of oxidative stress, cytokine production and nuclear factor kappa B

Environmental Toxicology and Pharmacology

Volumn 37, Issue 2, 2014, Pages 662-671

  Heeba, Gehan H ^a   Mahmoud, Magda E ^b  

^a Minia University   (Egypt)

^b Minia University   (Egypt)

Author keywords

Carbon tetrachloride; Liver fibrosis; Morin; Nuclear factor kappa B; Oxidative stress; Silymarin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLUTATHIONE; HYDROXYPROLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MESSENGER RNA; MORIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SILYMARIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; CARBON TETRACHLORIDE; FLAVONOID; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; PROTECTIVE AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBROTIC EFFECT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FUNCTION TEST; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CARBON TETRACHLORIDE; FLAVONOIDS; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; SILYMARIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896710299     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2014.01.026     Document Type: Article

References (33)

1. Ali S., Mann D.A. Signal transduction via the NF-κB pathway: a targeted treatment modality for infection inflammation and repair. Cell Biochem. Funct. 2004, 22:67-79.
2. Al-Numair K.S., Chandramohan G., Alsaif M.A. Pretreatment with morin, a flavonoid, ameliorates adenosine triphosphatases and glycoproteins in isoproterenol-induced myocardial infarction in rats. J. Nat. Med. 2012, 66:95-101.
3. Beutler E., Duron O., Kelly M.B. Improved method for determination of blood glutathione. J. Lab. Clin. Med. 1963, 61:882-887.
4. Chen W.P., Wang Y.L., Tang J.L., Hu P.F., Bao J.P., Wu L.D. Morin inhibits interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Int. Immunopharmacol. 2012, 12:447-452.
5. Johnston D.E., Kroening C. Mechanism of early carbon tetrachloride toxicity in cultured rat hepatocytes. Pharmacol. Toxicol. 1998, 83:231-239.
6. Kim J.M., Lee E.K., Park G., Kim M.K., Yokozawa T., Yu B.P., Chung H.Y. Morin modulates the oxidative stress-induced NF-κB pathway through its anti-oxidant activity. Free Radic. Res. 2010, 44:454-461.
7. Kitagawa S., Sakamoto H., Tano H. Inhibitory effects of flavonoids on free radical-induced hemolysis and their oxidative effects on hemoglobin. Chem. Pharm. Bull. 2004, 52:999-1001.
8. 4) in rat. Arch. Pharm. Res. 2008, 31:1160-1165.
9. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
10. Luedde T., Schwabe R.F. NF-κB in the liver-linking injury fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:108-118.
11. O'Dea E.L., Barken D., Peralta R.Q., Tran K.T., Werner S.L., Kearns J.D., Levchenko A., Hoffmann A. A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity. Mol. Syst. Biol. 2007, 3:111.
12. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
13. Orfila C., Lepert J.C., Alric L., Carrera G., Beraud M., Pipy B. Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferator activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochem. Cell Biol. 2005, 123:585-593.
14. Parola M., Robino G. Oxidative stress-related molecules and liver fibrosis. J. Hepatol. 2001, 35:297-306.
15. Pinzani M., Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig. Liver Dis. 2004, 36:231-242.
16. Prahalathan P., Kumar S., Raja B. Effect of morin a flavonoid against DOCA-salt hypertensive rats: a dose dependent study. Asian Pac. J. Trop. Biomed. 2012, 2:443-448.
17. Racanelli V., Rehermann B. The liver as an immunological organ. Hepatology 2006, 43:S54-S62.
18. Saller R., Meier R., Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs 2001, 61:2035-2063.
19. 4-induced hepatotoxicity in rats. Drug Chem. Toxicol. 2013, 36:42-47.
20. Sastry H., Moudgal R.P., Mohan J., Tyagi J.S., Rao G.S. Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal. Biochem. 2002, 306:79-82.
21. Shankari S.G., Karthikesan K., Jalaludeen A.M., Ashokkumar N. Hepatoprotective effect of morin on ethanol-induced hepatotoxicity in rats. J. Basic Clin. Physiol. Pharmacol. 2010, 21:277-294.
22. Sivaramakrishnan V., Devaraj S.N. Morin regulates the expression of NF-κB-p65 COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chem. Biol. Interact. 2009, 180:353-359.
23. Sivaramakrishnan V., Devaraj S.N. Morin fosters apoptosis in experimental hepatocellular carcinogenesis model. Chem. Biol. Interact. 2010, 183:284-292.
24. 4-induced liver injury and fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, S293:G631-G639.
25. Steib C.J., Gerbes A.L., Bystron M., Op den Winkel M., Hartl J., Rogggel F., Prufer T., Goke B., Bilzer M. Kupffer cell activation in normal and fibrotic livers increases, portal pressure via thromboxane A2. J. Hepatol. 2007, 47:228-238.
26. Subash S., Subramanian P. Morin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological study. Mol. Cell. Biochem. 2009, 327:153-161.
27. Thompson A.J., Patel K. Antifibrotic therapies: will we ever get there?. Curr. Gastroenterol. Rep. 2010, 12:23-29.
28. 4)-induced liver injury in mice. Toxicology 2010, 273:45-52.
29. Woessner J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 1961, 93:440-447.
30. Yachi R., Igarashi O., Kiyose C. Protective effects of vitamin e analogs against carbon tetrachloride-induced fatty liver in rats. J. Clin. Biochem. Nutr. 2010, 47:148-154.
31. Yuvaraj P., Subramoniam A. Hepatoprotective property of Thespesia populnea against carbon tetrachloride induced liver damage in rats. J. Basic Clin. Physiol. Pharmacol. 2009, 20:169-177.
32. Zhang A., Sun H., Wang X. Recent advances in natural products from plants for treatment of liver diseases. Eur. J. Med. Chem. 2013, 63:570-577.
33. Zhang R., Kang K.A., Kang S.S., Park J.W., Hyun J.W. Morin (2',3,4',5,7-pentahydroxyflavone) protected cells against radiation-induced oxidative stress. Basic Clin. Pharmacol. Toxicol. 2011, 108:63-72.